DISCLOSURE TRAINING PROGRAM

Sales and marketing disclosure mandates are sweeping the drug and devices industries. Massachusetts recently became the latest state to enact sales and marketing disclosure requirements, which take effect next year. Meanwhile, the Medicare Payment Advisory Commission (MedPAC) recently recommend that Congress require drug and device companies to publicly report spending on a broad range of categories including physicians, hospitals, continuing medical education (CME), professional organizations. MedPAC also recommended that companies disclose information about free drug samples to the Department of Health and Human Services. Senators Charles Grassley (R-IA) and Herb Kohl (D-WI) are expected to introduce a revised version of the Physician Payments Sunshine Act when Congress reconvenes next year.

In addition, the HHS Office of Inspector General recently included physician payment disclosure requirements in Cephalon's recent corporate integrity agreement (CIA). State Attorneys General included even more sweeping requirements in Eli Lilly's $62 million Zyprexa settlement and Pfizer's $60 million Bextra settlement.

The First Annual Summit on Sales & Marketing Disclosure for Drug, Device and Biotech Companies will examine these numerous mandates and how companies are responding. Expert panels will explore the latest state initiatives and how state and federal enforcers view disclosure as a compliance tool. Case studies will examine how companies can effectively comply with competing and overlapping requirements while adding value to the company's bottom line. The Summit brings together the key players shaping disclosure initiatives with the in-house and outside experts developing programs to comply in a cost-effective fashion.

• Pharmaceutical and Health Care Executives
• Medical Device Executives
• Compliance Officers
• Ethics Officers
• General Counsel and Legal Executives
• Finance Executives
• Information Management and Information Technology Executives
• Medical Affairs Directors
• Food and Drug Law Attorneys
• Privacy Officers
• Auditors
• Food and Drug Law Attorneys
• Pharmaceutical Consultants
• Health Care Regulators and Policy Makers
• Health Services Researchers and Academics